Testosterone Therapy Shows Mixed Effects on Shoulder Surgery Recovery

This groundbreaking study addresses a critical question for the growing number of men using testosterone replacement therapy who need shoulder surgery. As both testosterone use and rotator cuff repairs become more common in aging populations, understanding their interaction is vital for optimizing surgical outcomes and longevity.

Researchers analyzed data from over 680,000 patients who underwent arthroscopic rotator cuff repair between 2010 and 2023. They compared 5,109 men who received testosterone therapy within three months before surgery to an equal number of matched controls, following outcomes for two years.

The results were reassuring for short-term safety. Testosterone users showed no increased risk of immediate complications like infections, blood clots, pneumonia, or hospital readmissions within 90 days. This suggests testosterone therapy doesn't compromise initial healing or increase surgical risks.

However, longer-term patterns were more complex. Testosterone users were 75% more likely to eventually need total shoulder replacement, suggesting possible issues with repair durability or joint health. Conversely, they were 44% less likely to require surgery for shoulder stiffness, indicating potentially better mobility outcomes.

For health-conscious individuals, this research suggests testosterone therapy doesn't preclude successful shoulder surgery, but may influence healing trajectories. The mixed long-term outcomes highlight the importance of individualized treatment decisions and careful monitoring. While testosterone therapy appears safe perioperatively, patients and physicians should discuss potential long-term trade-offs between joint replacement risk and mobility preservation when planning treatment strategies.